Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Tem

Short Sellers Are Taking Aim at Buy-Rated Tempus AI. Should You Buy TEM Stock Here?

Tempus AI stock fell over 19% after Spruce Point Capital released a short report. Can TEM stock recover?

Tempus AI Stock: Time to Double Down or Cut and Run?

Tempus AI Stock: Time to Double Down or Cut and Run?

Tempus AI is gaining traction and on track for profits this year; high short interest and rising institutional activity point to significant upside potential.

3 Hot New IPOs Defying the 2025 Market Slump

3 Hot New IPOs Defying the 2025 Market Slump

Tempus AI, ServiceTitan, and CoreWeave are 2025 IPO standouts, defying a down market. Here’s how they’re beating the S&P 500 so far this year.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Nancy Pelosi's 2025 Stock Buys Worth $1.95M are Deep in Red, Some as Much as 57%

Former House Speaker Nancy Pelosi purchased call option contracts of companies, including Alphabet, Amazon, Nvidia, Vistra Corp, and Tempus AI, in January.

International Business Times UK

Cathie Wood Loves This Under-the-Radar AI Stock. Is It Time for You to Buy Now?

The popular investor poured $366.2 million in the company’s shares to carry out her latest purchase.

Tempus AI Is a Buy, If You Can Handle the Volatility

Tempus AI is well-positioned to capitalize on its extensive clinical data database. It can provide personalized treatment for hard-to-treat illness.

Conflicting Signals: Tempus AI's Stock Market Rally

Tempus AI's stock has soared on completed acquisitions and product launches, yet mixed analyst sentiment signals a need for careful investor review.

inkl

Read news from The Economist, FT, and more,
with one subscription

Cathie Wood Just Doubled Down on This AI Stock. Should You?

Cathie Wood Just Doubled Down on This AI Stock. Should You?

The stock is one of the renowned investor’s top holdings.

Tempus AI: A Game-Changer in AI-Powered Healthcare

Tempus AI: A Game-Changer in AI-Powered Healthcare

TEM surged 35% on Tuesday, fueled by the launch of its AI-powered health app Olivia and news of Nancy Pelosi's disclosed call option position in the stock.

Pelosi Sells 31K Apple and 10K Nvidia Shares, Eyes New AI and Utility Firm in a Major Portfolio Reshuffle

Pelosi Sells 31K Apple and 10K Nvidia Shares, Eyes New AI and Utility Firm in a Major Portfolio Reshuffle

Pelosi sold Apple and Nvidia shares while betting on Tempus AI and Vistra Corp. She also bought call options for both Amazon and Alphabet Class A stocks.

International Business Times UK

1 AI Stock Cathie Wood Is Buying Instead of Tesla

1 AI Stock Cathie Wood Is Buying Instead of Tesla

Cathie Wood is shifting away from Tesla, zeroing in on an AI-driven healthcare firm that is revolutionizing precision medicine and advanced diagnostics.

Should You Follow Cathie Wood Into This AI Diagnostics Stock?

Should You Follow Cathie Wood Into This AI Diagnostics Stock?

This AI diagnostics stock is a holding in Wood's ARKK and ARKG ETFs.

People

119,643 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

276,866 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play